Navigation Links
Breckenridge Pharmaceutical signs Letter of Intent with Welding GmbH & Co & SK Chemicals

BOCA RATON, Fla., June 10, 2013 /PRNewswire/ -- Breckenridge announced today that it has entered into a Development Agreement with Welding GmbH & Co and SK Chemicals to develop and market an ANDA with U.S. branded sales of approximately $500M. Under the terms of this agreement, Welding and SK will develop and manufacture the product, utilizing SK's advanced drug delivery system, for Breckenridge Pharmaceutical, Inc., who will have exclusive marketing and distribution rights in the U.S. This agreement further supports Breckenridge's interest in leveraging drug delivery technologies to diversify its product development pipeline. 

About Breckenridge:
Breckenridge is a privately-held pharmaceutical marketing, research and development company founded in 1983 that markets a broad range of generic prescription products and Medical Foods in many therapeutic categories. The Breckenridge label is recognized by Wholesalers, Distributors, Chains, and Managed Care Accounts, as well as Retail Pharmacies nationwide. The company markets over 60 products in a variety of dosage forms including: Tablets, Capsules, Soft Gel Capsules, and Liquids, and Powders.

About Welding:
Welding is a privately owned company, headquartered in Hamburg, Germany. Founded in 1955, with subsidiaries in Frankfurt and Lyon, France, Welding has an ever increasing global presence. Core competences are the development, registration, licensing, and supply of generic finished products. Welding tackles the challenges of the global pharmaceutical market with fully compliant and complete generic development solutions for the generic industry, including but not limited to API sourcing, development of API syntheses, Intellectual Property vetting and review, regulatory affairs, launch and supply chain management. In addition Welding understands the important role and responsibility that we have as a premier partner in global marketing, sourcing and distribution of active pharmaceutical ingredients.

About SK Chemicals:
Since its formation in 1969, SK Chemicals has grown into one of the major healthcare and chemical company in Korea via continuous series of innovations. Now, the company is trying to leap forward by reorganizing its corporate structure into Green Chemicals and Life Science, under the mandate, 'Improve human health and project the global environment.'

When it comes to Life Science Business, SK Chemicals are deploying a portfolio of diverse products in push for value-oriented development activities. The accumulated key competency through consistent R&D investment to expand into the global marketplaces enables SK Chemicals to succeed in a series of out-licensing deals and achievements in a patentable PPI oral tablet, a reformulated anticancer injectable and human recombinant factor followed by the marketing authorizations of a few products in Europe and the States.

SOURCE Breckenridge
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Breckenridge Announces Approval for Pioglitazone Hydrochloride tablets
2. Breckenridge announces agreement with Aptalis Pharmatech to market Propranolol Hydrochloride Extended-Release Capsules
3. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
4. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
5. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
6. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
7. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
8. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
9. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
10. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
11. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
Post Your Comments:
(Date:12/1/2015)... 2015 /PRNewswire/ -- Royal Philips  (NYSE: ... X-ray imaging software that produces high-contrast images for all ... a grid, at the 2015 Radiological Society of ... is Philips, first digital imaging solution providing grid-like contrast ... clinician,s workflow and supports "first-time-right imaging" by decreasing the ...
(Date:12/1/2015)... PUNE, India , December 1, 2015 ... new market research report "Immunotherapy Drugs Market by Type of ... Vaccines), Checkpoint Inhibitors), Epidemiology, Regulatory and Pipeline Analysis - Global ... Market is poised to reach USD 73,529.2 Million by 2020 ... 12.8% from 2015 to 2020. Browse ...
(Date:12/1/2015)... MASON, Ohio , Dec. 1, 2015 /PRNewswire/ ... enhancement to its GeneSight® Psychotropic test giving healthcare providers ... make medication decisions for patients suffering from depression, ... and other behavioral health conditions. ...   --> With the addition of ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... 2015 , ... CloudLIMS today announced that it is the ... the New Products and Services category for its innovative product offering, BioTracer. ... that helps labs organize data and track samples with storage inventories. BioTracer's SaaS ...
(Date:12/1/2015)... ... December 01, 2015 , ... Diabetic foot ... States. Podiatrists are well aware that psychology-based patient non-compliance (disobedience of a health ... contributors to diseases of the diabetic foot. The American Board of Multiple ...
(Date:12/1/2015)... IL (PRWEB) , ... December 01, 2015 , ... ... keeping their independence is everything. That is why Hollister Incorporated has launched the ... to offer this next product in the VaPro touch free catheter portfolio,” said ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... has been selected as a finalist in this year’s Fierce Innovation Awards: Healthcare ... IT Healthcare was recognized as a finalist in the category of Digital Solutions ...
(Date:12/1/2015)... ... 2015 , ... TCS Healthcare Technologies (TCS), a leading provider ... is pleased to announce that VIP Care Services, a Caprock Health Group affiliate ... Complete Care™ Management to back their collaborative catastrophic case management initiatives. ACUITY Complete ...
Breaking Medicine News(10 mins):